Global Pediatric Respiratory Syncytial Virus Infection Market Research Report 2023
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Respiratory Syncytial Virus Infection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Bronchodilators
1.2.3 Alpha agonists
1.2.4 Ribavirin
1.3 Market by Application
1.3.1 Global Pediatric Respiratory Syncytial Virus Infection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Respiratory Syncytial Virus Infection Market Perspective (2018-2029)
2.2 Pediatric Respiratory Syncytial Virus Infection Growth Trends by Region
2.2.1 Global Pediatric Respiratory Syncytial Virus Infection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pediatric Respiratory Syncytial Virus Infection Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Respiratory Syncytial Virus Infection Forecasted Market Size by Region (2024-2029)
2.3 Pediatric Respiratory Syncytial Virus Infection Market Dynamics
2.3.1 Pediatric Respiratory Syncytial Virus Infection Industry Trends
2.3.2 Pediatric Respiratory Syncytial Virus Infection Market Drivers
2.3.3 Pediatric Respiratory Syncytial Virus Infection Market Challenges
2.3.4 Pediatric Respiratory Syncytial Virus Infection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Respiratory Syncytial Virus Infection Players by Revenue
3.1.1 Global Top Pediatric Respiratory Syncytial Virus Infection Players by Revenue (2018-2023)
3.1.2 Global Pediatric Respiratory Syncytial Virus Infection Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Respiratory Syncytial Virus Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Respiratory Syncytial Virus Infection Revenue
3.4 Global Pediatric Respiratory Syncytial Virus Infection Market Concentration Ratio
3.4.1 Global Pediatric Respiratory Syncytial Virus Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Respiratory Syncytial Virus Infection Revenue in 2022
3.5 Pediatric Respiratory Syncytial Virus Infection Key Players Head office and Area Served
3.6 Key Players Pediatric Respiratory Syncytial Virus Infection Product Solution and Service
3.7 Date of Enter into Pediatric Respiratory Syncytial Virus Infection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Respiratory Syncytial Virus Infection Breakdown Data by Type
4.1 Global Pediatric Respiratory Syncytial Virus Infection Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Respiratory Syncytial Virus Infection Forecasted Market Size by Type (2024-2029)
5 Pediatric Respiratory Syncytial Virus Infection Breakdown Data by Application
5.1 Global Pediatric Respiratory Syncytial Virus Infection Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Respiratory Syncytial Virus Infection Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pediatric Respiratory Syncytial Virus Infection Market Size (2018-2029)
6.2 North America Pediatric Respiratory Syncytial Virus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2018-2023)
6.4 North America Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Respiratory Syncytial Virus Infection Market Size (2018-2029)
7.2 Europe Pediatric Respiratory Syncytial Virus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2018-2023)
7.4 Europe Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Size (2018-2029)
8.2 Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Size by Region (2018-2023)
8.4 Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Respiratory Syncytial Virus Infection Market Size (2018-2029)
9.2 Latin America Pediatric Respiratory Syncytial Virus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2018-2023)
9.4 Latin America Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Size (2018-2029)
10.2 Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2018-2023)
10.4 Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ablynx NV
11.1.1 Ablynx NV Company Detail
11.1.2 Ablynx NV Business Overview
11.1.3 Ablynx NV Pediatric Respiratory Syncytial Virus Infection Introduction
11.1.4 Ablynx NV Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
11.1.5 Ablynx NV Recent Development
11.2 Aridis Pharmaceutical
11.2.1 Aridis Pharmaceutical Company Detail
11.2.2 Aridis Pharmaceutical Business Overview
11.2.3 Aridis Pharmaceutical Pediatric Respiratory Syncytial Virus Infection Introduction
11.2.4 Aridis Pharmaceutical Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
11.2.5 Aridis Pharmaceutical Recent Development
11.3 Artificial Cell Technologies
11.3.1 Artificial Cell Technologies Company Detail
11.3.2 Artificial Cell Technologies Business Overview
11.3.3 Artificial Cell Technologies Pediatric Respiratory Syncytial Virus Infection Introduction
11.3.4 Artificial Cell Technologies Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
11.3.5 Artificial Cell Technologies Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Detail
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Pediatric Respiratory Syncytial Virus Infection Introduction
11.4.4 Astellas Pharma Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
11.4.5 Astellas Pharma Recent Development
11.5 ClearPath Development
11.5.1 ClearPath Development Company Detail
11.5.2 ClearPath Development Business Overview
11.5.3 ClearPath Development Pediatric Respiratory Syncytial Virus Infection Introduction
11.5.4 ClearPath Development Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
11.5.5 ClearPath Development Recent Development
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Detail
11.6.2 Bavarian Nordic Business Overview
11.6.3 Bavarian Nordic Pediatric Respiratory Syncytial Virus Infection Introduction
11.6.4 Bavarian Nordic Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
11.6.5 Bavarian Nordic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Pediatric Respiratory Syncytial Virus Infection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Alpha agonists
Table 4. Key Players of Ribavirin
Table 5. Global Pediatric Respiratory Syncytial Virus Infection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Pediatric Respiratory Syncytial Virus Infection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Pediatric Respiratory Syncytial Virus Infection Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Pediatric Respiratory Syncytial Virus Infection Market Share by Region (2018-2023)
Table 9. Global Pediatric Respiratory Syncytial Virus Infection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Pediatric Respiratory Syncytial Virus Infection Market Share by Region (2024-2029)
Table 11. Pediatric Respiratory Syncytial Virus Infection Market Trends
Table 12. Pediatric Respiratory Syncytial Virus Infection Market Drivers
Table 13. Pediatric Respiratory Syncytial Virus Infection Market Challenges
Table 14. Pediatric Respiratory Syncytial Virus Infection Market Restraints
Table 15. Global Pediatric Respiratory Syncytial Virus Infection Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Pediatric Respiratory Syncytial Virus Infection Market Share by Players (2018-2023)
Table 17. Global Top Pediatric Respiratory Syncytial Virus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Respiratory Syncytial Virus Infection as of 2022)
Table 18. Ranking of Global Top Pediatric Respiratory Syncytial Virus Infection Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Pediatric Respiratory Syncytial Virus Infection Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pediatric Respiratory Syncytial Virus Infection Product Solution and Service
Table 22. Date of Enter into Pediatric Respiratory Syncytial Virus Infection Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Respiratory Syncytial Virus Infection Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Pediatric Respiratory Syncytial Virus Infection Revenue Market Share by Type (2018-2023)
Table 26. Global Pediatric Respiratory Syncytial Virus Infection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Pediatric Respiratory Syncytial Virus Infection Revenue Market Share by Type (2024-2029)
Table 28. Global Pediatric Respiratory Syncytial Virus Infection Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Pediatric Respiratory Syncytial Virus Infection Revenue Market Share by Application (2018-2023)
Table 30. Global Pediatric Respiratory Syncytial Virus Infection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Pediatric Respiratory Syncytial Virus Infection Revenue Market Share by Application (2024-2029)
Table 32. North America Pediatric Respiratory Syncytial Virus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Pediatric Respiratory Syncytial Virus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Pediatric Respiratory Syncytial Virus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Size by Country (2024-2029) & (US$ Million)
Table 47. Ablynx NV Company Detail
Table 48. Ablynx NV Business Overview
Table 49. Ablynx NV Pediatric Respiratory Syncytial Virus Infection Product
Table 50. Ablynx NV Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023) & (US$ Million)
Table 51. Ablynx NV Recent Development
Table 52. Aridis Pharmaceutical Company Detail
Table 53. Aridis Pharmaceutical Business Overview
Table 54. Aridis Pharmaceutical Pediatric Respiratory Syncytial Virus Infection Product
Table 55. Aridis Pharmaceutical Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023) & (US$ Million)
Table 56. Aridis Pharmaceutical Recent Development
Table 57. Artificial Cell Technologies Company Detail
Table 58. Artificial Cell Technologies Business Overview
Table 59. Artificial Cell Technologies Pediatric Respiratory Syncytial Virus Infection Product
Table 60. Artificial Cell Technologies Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023) & (US$ Million)
Table 61. Artificial Cell Technologies Recent Development
Table 62. Astellas Pharma Company Detail
Table 63. Astellas Pharma Business Overview
Table 64. Astellas Pharma Pediatric Respiratory Syncytial Virus Infection Product
Table 65. Astellas Pharma Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023) & (US$ Million)
Table 66. Astellas Pharma Recent Development
Table 67. ClearPath Development Company Detail
Table 68. ClearPath Development Business Overview
Table 69. ClearPath Development Pediatric Respiratory Syncytial Virus Infection Product
Table 70. ClearPath Development Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023) & (US$ Million)
Table 71. ClearPath Development Recent Development
Table 72. Bavarian Nordic Company Detail
Table 73. Bavarian Nordic Business Overview
Table 74. Bavarian Nordic Pediatric Respiratory Syncytial Virus Infection Product
Table 75. Bavarian Nordic Revenue in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023) & (US$ Million)
Table 76. Bavarian Nordic Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Pediatric Respiratory Syncytial Virus Infection Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Pediatric Respiratory Syncytial Virus Infection Market Share by Type: 2022 VS 2029
Figure 3. Bronchodilators Features
Figure 4. Alpha agonists Features
Figure 5. Ribavirin Features
Figure 6. Global Pediatric Respiratory Syncytial Virus Infection Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Pediatric Respiratory Syncytial Virus Infection Market Share by Application: 2022 VS 2029
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Clinics Case Studies
Figure 12. Pediatric Respiratory Syncytial Virus Infection Report Years Considered
Figure 13. Global Pediatric Respiratory Syncytial Virus Infection Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Pediatric Respiratory Syncytial Virus Infection Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Pediatric Respiratory Syncytial Virus Infection Market Share by Region: 2022 VS 2029
Figure 16. Global Pediatric Respiratory Syncytial Virus Infection Market Share by Players in 2022
Figure 17. Global Top Pediatric Respiratory Syncytial Virus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Respiratory Syncytial Virus Infection as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Pediatric Respiratory Syncytial Virus Infection Revenue in 2022
Figure 19. North America Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Pediatric Respiratory Syncytial Virus Infection Market Share by Country (2018-2029)
Figure 21. United States Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Pediatric Respiratory Syncytial Virus Infection Market Share by Country (2018-2029)
Figure 25. Germany Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Pediatric Respiratory Syncytial Virus Infection Market Share by Region (2018-2029)
Figure 33. China Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Pediatric Respiratory Syncytial Virus Infection Market Share by Country (2018-2029)
Figure 41. Mexico Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Pediatric Respiratory Syncytial Virus Infection Market Share by Country (2018-2029)
Figure 45. Turkey Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Pediatric Respiratory Syncytial Virus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Ablynx NV Revenue Growth Rate in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
Figure 48. Aridis Pharmaceutical Revenue Growth Rate in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
Figure 49. Artificial Cell Technologies Revenue Growth Rate in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
Figure 50. Astellas Pharma Revenue Growth Rate in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
Figure 51. ClearPath Development Revenue Growth Rate in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
Figure 52. Bavarian Nordic Revenue Growth Rate in Pediatric Respiratory Syncytial Virus Infection Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed